Redox reactions of neurotransmitters possibly involved in the progression of Parkinson's Disease.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Journal of Inorganic Biochemistry

• Publication date

  2000-04-30

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/S0162-0134(99)00238-XPMID 10830883
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Inorganic biochemistry of iron metabolism

  2001cited by this paper
• Iron in Central Nervous System Disorders

  2001cited by this paper
• Free Radicals in Brain Pathophysiology

  2000cited by this paper
• The Role of Iron in Neurodegeneration

  1999cited by this paper
• Improving Outcomes in Elderly Patients with Asthma

  1999cited by this paper
• In vitro and in vivo studies investigating possible antioxidant actions of nicotine: relevance to Parkinson's and Alzheimer's diseases.

  1999cited by this paper
• A kinetic study of the reaction between noradrenaline and iron(III): an example of parallel inner- and outer-sphere electron transfer

  1998cited by this paper
• In Vitro Studies of Ferritin Iron Release and Neurotoxicity

  1998cited by this paper
• Anaerobic oxidation of dopamine by iron(III)

  1997cited by this paper
• Dopamine, 6-hydroxydopamine, iron, and dioxygen--their mutual interactions and possible implication in the development of Parkinson's disease.

  1996cited by this paper
• Spontaneous autoxidation of dopamine

  1995cited by this paper
• Manganese(II) catalysis of the autoxidation of dopamine resulting from dioxygen adduct formation

  1995cited by this paper
• Iron- and peroxide-dependent conjugation of dopamine with cysteine: oxidative routes to the novel brain metabolite 5-S-cysteinyldopamine.

  1995cited by this paper
• The role of transition metals in the pathogenesis of Parkinson's disease.

  1995cited by this paper
• Effects of L-cysteine on the oxidation chemistry of dopamine: new reaction pathways of potential relevance to idiopathic Parkinson's disease.

  1994cited by this paper
• Distribution of iron in the basal ganglia and neocortex in postmortem tissue in Parkinson's disease and Alzheimer's disease.

  1993cited by this paper
• The possible role of iron in the etiopathology of parkinson's disease

  1993cited by this paper
• Iron deposits in brain disorders

  1993cited by this paper
• A kinetic study of the anaerobic reactions between adrenaline and iron(III)

  1993cited by this paper
• The determination of hydroxydopamines and other trace amines in the urine of Parkinsonian patients and normal controls

  1993cited by this paper
• The Fenton reagents.

  1993cited by this paper
• Is the Vulnerability of Neurons in the Substantia Nigra of Patients with Parkinson's Disease Related to Their Neuromelanin Content?

  1992cited by this paper
• Oxidative stress as a cause of nigral cell death in Parkinson's disease and incidental lewy body disease

  1992cited by this paper
• Why are nigral catecholaminergic neurons more vulnerable than other cells in Parkinson's disease?

  1992cited by this paper
• Alterations in levels of iron, ferritin, and other trace metals in neurodegenerative diseases affecting the basal ganglia

  1992cited by this paper
• Distribution of iron in different brain regions and subcellular compartments in Parkinson's disease

  1992cited by this paper
• Modulation by neuromelanin of the availability and reactivity of metal ions

  1992cited by this paper
• Iron‐Melanin Complex in Substantia Nigra of Parkinsonian Brains: An X‐Ray Microanalysis

  1992cited by this paper
• Protection of substantia nigra from MPP+ neurotoxicity by N-methyl-D-aspartate antagonists

  1991cited by this paper
• Oxidative stress as a cause of Parkinson's disease

  1991cited by this paper
• The Iron Chelator Desferrioxamine (Desferal) Retards 6‐Hydroxydopamine‐Induced Degeneration of Nigrostriatal Dopamine Neurons

  1991cited by this paper
• Complex formation followed by internal electron transfer: the reaction between L-dopa and iron(III)

  1991cited by this paper
• Ageing and Parkinson's disease: substantia nigra regional selectivity.

  1991cited by this paper
• An Improved HPLC‐Electrochemical Detection Method for Measuring Brain Levels of 5‐S‐Cysteinyldopamine, 5‐S‐Cysteinyl‐3,4‐Dihydroxyphenylalanine, and 5‐S‐Cysteinyl‐3,4‐Dihydroxyphenylacetic Acid

  1990cited by this paper
• 6-Hydroxydopamine releases iron from ferritin and promotes ferritin-dependent lipid peroxidation.

  1989cited by this paper
• The apparent autoxidation rate of catechols in dopamine-rich regions of human brains increases with the degree of depigmentation of substantia nigra

  1989cited by this paper
• The oxovanadyl(IV) catalysed oxidation of adrenaline by molecular oxygen

  1986cited by this paper
• Synthesis and physicochemical and neurotoxicity studies of 1-(4-substituted-2,5-dihydroxyphenyl)-2-aminoethane analogues of 6-hydroxydopamine.

  1984cited by this paper
• Metalloproteins with phenolate coordination

  1983cited by this paper
• Dioxygenase models. Crystal structures of [N,N'-(1,2-phenylene)bis(salicylideniminato)](catecholato-O)iron(III) and .mu.-(1,4-benzenediolato-O,O')-bis[N,N'-ethylenebis(salicylideniminato)iron(III)]

  1982cited by this paper
• One-electron redox potentials of phenols. Hydroxy- and aminophenols and related compounds of biological interest

  1982cited by this paper
• Mechanism and kinetics of iron release from ferritin by dihydroflavins and dihydroflavin analogues.

  1978cited by this paper
• The Oxidation of Aromatic Ortho-diols by Periodic Acid. Kinetics and Mechanism

  1976cited by this paper
• Intracyclization rates of 6-hydroxydopamine and 6-aminodopamine analogs under physiological conditions.

  1976cited by this paper
• Mobilisation of iron from ferritin fractions of defined iron content by biological reductants

  1975cited by this paper
• The Chemistry Of Adrenochrome And Related Compounds

  1959cited by this paper
• Inorganic Free Radicals in Solution.

  1952cited by this paper
• The catalytic decomposition of hydrogen peroxide by iron salts

  1934cited by this paper
• LXXIII.—Oxidation of tartaric acid in presence of iron

  year unknowncited by this paper

• Gradients of Nigrostriatal Iron Deposition in Healthy Aging and Synucleinopathies

  2025cites this paper
• Biological Characterization of the Anti-ferroptotic Properties of a Novel Anti-Parkinsonian Iron (II) Selective Dopamine Agonist, D-583

  2025cites this paper
• Iron ions-sequestrable and antioxidative carbon dot-based nano-formulation with nitric oxide release for Parkinson's disease treatment.

  2024cites this paper
• Paper-in-Tip Bipolar Electrospray Mass Spectrometry for Real-Time Chemical Reaction Monitoring.

  2024cites this paper
• Unscrambling the Role of Redox-Active Biometals in Dopaminergic Neuronal Death and Promising Metal Chelation-Based Therapy for Parkinson’s Disease

  2023cites this paper
• The interactions of polyphenols with Fe and their application in Fenton/Fenton-like reactions

  2022cites this paper
• Mitochondria: Bioenergetics and Predictive Therapeutics Using Vibrational Spectroscopy

  2021cites this paper
• Ferritin disorder in the plasma and hippocampus associated with major depressive disorder.

  2021cites this paper
• The mobility and solvation structure of a hydroxyl radical in a water nanodroplet: a Born-Oppenheimer molecular dynamics study.

  2021cites this paper
• Surface Plasmon Resonance Identifies High-Affinity Binding of l-DOPA to Siderocalin/Lipocalin-2 through Iron-Siderophore Action: Implications for Parkinson's Disease Treatment.

  2021cites this paper
• Knockout fth1b affects early mineralization of zebrafish pharyngeal teeth.

  2021cites this paper
• Toxic Feedback Loop Involving Iron, Reactive Oxygen Species, α-Synuclein and Neuromelanin in Parkinson’s Disease and Intervention with Turmeric

  2021cites this paper
• The water trimer reaction OH + (H2O)3 → (H2O)2OH + H2O.

  2020cites this paper
• Measurement uncertainty evaluation of the Total Antioxidant Capacity of human plasma tested by the CUPRAC-BCS method

  2020cites this paper
• The Striatal DNA Damage and Neurodegenerations

  2020cites this paper
• KINETIC STUDY OF Fe(II) AND Fe(III) COMPLEXES OF DOPAMINE, (-)3-(3,4-DIHYDROXYPHENYL)-L-ALANINE AT PHYSIOLOGICAL pH

  2020cites this paper
• Hydrogen Abstraction Reaction H2Se + OH → H2O + SeH: Comparison with the Analogous Hydrogen Sulfide and Water Reactions.

  2019cites this paper
• Metabolic Characterization of Cellular Health Using a Multimodal Spectroscopy Technique

  2019cites this paper
• Iron chelator Deferoxamine protects human neuroblastoma cell line SH-SY5Y from 6-Hydroxydopamine-induced apoptosis and autophagy dysfunction.

  2019cites this paper
• Bis(nitroxide) methanofullerene as SOD-mimetic in reactions with catecholamines

  2019cites this paper
• Biogenic Aldehyde-Mediated Mechanisms of Toxicity in Neurodegenerative Disease.

  2019cites this paper
• OH radical in water from ab initio molecular dynamics simulation employing hybrid functionals

  2019cites this paper
• Norepinephrine-Fe(III)-ATP Ternary Complex and Its Relevance to Parkinson's Disease.

  2019cites this paper
• Pathogenesis, diagnosis and treatment strategies of Parkinson's disease

  2018cites this paper
• A review on iron chelators as potential therapeutic agents for the treatment of Alzheimer’s and Parkinson’s diseases

  2018cites this paper
• Miniaturized FDDA and CMOS Based Potentiostat for Bio-Applications

  2017cites this paper
• Crosstalk between endoplasmic reticulum stress and oxidative stress in schizophrenia: The dawn of new therapeutic approaches

  2017cites this paper
• Melatonin Supplementation in Neurodegenerative Diseases: Current Status

  2016cites this paper
• Ferroptosis, a newly characterized form of cell death in Parkinson's disease that is regulated by PKC.

  2016influential citation
• Alginate/magnetite hybrid beads for magnetically stimulated release of dopamine.

  2016cites this paper
• Mise en évidence de l’implication d’une mort cellulaire dépendante du fer, la ferroptose, dans des modèles de la maladie de Parkinson

  2016influential citation
• Reduction reactivity of catecholamines and their ability to promote a Fenton reaction

  2016cites this paper
• Relationships between iron, oxidative stress, glycated proteins and the development of atherosclerosis in Type 2 diabetes

  2015cites this paper
• Papel de la melotonina en la enfermedad de Alzheimer y otras enfermedades neurodegenerativas

  2015cites this paper
• Detection of dopamine on a mercapto-terminated hexanuclear Fe(III) cluster modified gold electrode.

  2015cites this paper
• Assessment of Protective Role of Multifunctional Dopamine Agonist D-512 Against Oxidative Stress Produced by Depletion of Glutathione in PC12 Cells: Implication in Neuroprotective Therapy for Parkinson’s Disease

  2015cites this paper
• Reactivity of catecholamine-driven Fenton reaction and its relationships with iron(III) speciation

  2015cites this paper
• The importance of traditional uses and nutraceutical aspects of some edible wild plants in human nutrition: the case of Umbria (central Italy)

  2014cites this paper
• Mitochondria oxidative injury of dopaminergic neuron in Parkinson's disease

  2014cites this paper
• Electrochemical investigation of the redox couple Fe(III)/Fe(II) in the presence of amino acids and neurotransmitters

  2014cites this paper
• The high‐affinity D2/D3 agonist D512 protects PC12 cells from 6‐OHDA‐induced apoptotic cell death and rescues dopaminergic neurons in the MPTP mouse model of Parkinson's disease

  2014cites this paper
• Role of melatonin supplementation in neurodegenerative disorders.

  2014cites this paper
• Inhibition of the Fe(III)-catalyzed dopamine oxidation by ATP and its relevance to oxidative stress in Parkinson's disease.

  2013cites this paper
• Ferritin in the antiphospholipid syndrome and its catastrophic variant (cAPS)

  2013cites this paper
• Measurement of total antioxidant capacity of human plasma: setting and validation of the CUPRAC-BCS method on routine apparatus ADVIA 2400.

  2013cites this paper
• Progress Towards Understanding Of Mechanisms Of Action Of Potent Multifunctional Disease Modifying Therapeutics For Parkinson's Disease & Investigating The Methamphetamine-Induced Striatal Microglia Activation.

  2013cites this paper
• Ferritin iron uptake and release in the presence of metals and metalloproteins: Chemical implications in the brain

  2013cites this paper
• D-512 and D-440 as novel multifunctional dopamine agonists: characterization of neuroprotection properties and evaluation of in vivo efficacy in a Parkinson's disease animal model.

  2013cites this paper
• Ferritin in Adult-Onset Still's Disease: Just a Useful Innocent Bystander?

  2012cites this paper
• Magnetic anisotropy considerations in magnetic force microscopy studies of single superparamagnetic nanoparticles

  2012cites this paper
• Iron, cysteine and neurodegeneration during Parkinson’s disease

  2012cites this paper
• Adult Onset Still's Disease and Autoinflammation

  2012cites this paper
• Altered transcription factor trafficking in oxidatively-stressed neuronal cells.

  2012cites this paper
• Nuclear transport, oxidative stress, and neurodegeneration.

  2011cites this paper
• Oxidative Stress in Schizophrenia

  2011cites this paper
• ROS Initiated Oxidation of Dopamine under Oxidative Stress Conditions in Aqueous and Lipidic Environments

  2011cites this paper
• Different Mechanisms Between Copper and Iron in Catecholamines-Mediated Oxidative DNA Damage and Disruption of Gene Expression In Vitro

  2011cites this paper
• Dopamine-loaded chitosan nanoparticles: formulation and analytical characterization

  2011cites this paper
• Molecular dynamics study of the hydration of the hydroxyl radical at body temperature.

  2011cites this paper
• Iron, cysteine and Parkinson’s disease

  2011cites this paper
• Ferritin Diversity: Mechanistic Studies, Disease Implications, and Materials Chemistry

  2011cites this paper
• Early toxic effect of 6-hydroxydopamine on extracellular concentrations of neurotransmitters in the rat striatum: an in vivo microdialysis study.

  2010cites this paper
• Experimental and theoretical analysis of polymerization reaction process on the polydopamine membranes and its corrosion protection properties for 304 Stainless Steel

  2010cites this paper
• Native and synthetic ferritins for nanobiomedical applications: recent advances and new perspectives.

  2010cites this paper
• Oxido-reduction is not the only mechanism allowing ions to traverse the ferritin protein shell.

  2010cites this paper
• Investigation of the Protein Components of the Zebra Mussel (Dreissena polymorpha) Byssal Adhesion Apparatus

  2010cites this paper
• Melanin Made by Dopamine Oxidation: Thin Films and Interactions with Polyelectrolyte Multilayers

  2010cites this paper
• A study of the aerobic reaction between dopamine and Fe(III) in the presence of S2O32−

  2009cites this paper
• The detection of hydroxyl radicals in vivo.

  2008cites this paper
• IRON METABOLISM IN AN IN VITRO MODEL OF CARDIAC ISCHEMIA : HYPOXIC INJURY AND PROTECTIVE STRATEGIES

  2008cites this paper
• IRON METABOLISM IN AN IN VITRO MODEL OF CARDIAC ISCHEMIA : HYPOXIC INJURY AND PROTECTIVE STRATEGIES

  2008cites this paper
• Neurochemical pathways involved in the protective effects of nicotine and ethanol in preventing the development of Parkinson's disease: potential targets for the development of new therapeutic agents.

  2008cites this paper
• Control of the surface charges of Au-Ag nanorods: selective detection of iron in the presence of poly(sodium 4-styrenesulfonate).

  2007cites this paper
• Carbohydrate effect: hormone and oxidative changes.

  2007cites this paper
• Ethnic difference in the relationship between acute inflammation and serum ferritin in US adult males

  2007cites this paper
• Iron Storage within Dopamine Neurovesicles Revealed by Chemical Nano-Imaging

  2007cites this paper
• Carbohydrate Effect: Hormone and Oxidative Changes

  2007cites this paper
• Ferritin in autoimmune diseases.

  2007cites this paper
• Influence of carbohydrate, intense exercise, and rest intervals on hormonal and oxidative changes.

  2007cites this paper
• Contribution of genomics and proteomics in understanding the role of modifying factors in Parkinson's disease.

  2006cites this paper
• Intranigral Dopamine Toxicity and α-Synuclein Response in Rats

  2006cites this paper
• Intranigral dopamine toxicity and alpha-synuclein response in rats.

  2006cites this paper
• Chemokine CXCL12 Induces Binding of Ferritin Heavy Chain to the Chemokine Receptor CXCR4, Alters CXCR4 Signaling, and Induces Phosphorylation and Nuclear Translocation of Ferritin Heavy Chain*

  2006cites this paper
• Neurotoxic dopamine quinone facilitates the assembly of tau into fibrillar polymers

  2005cites this paper
• Solvation structure of hydroxyl radical by Car-Parrinello molecular dynamics.

  2005cites this paper
• The Vibrational Structure of the OH Radical in Solid Argon: A Transfer- Matrix Path-Integral Approach

  2005cites this paper
• Divergent modulation of iron regulatory proteins and ferritin biosynthesis by hypoxia/reoxygenation in neurones and glial cells

  2005cites this paper
• Release of iron from ferritin by aceto- and benzohydroxamic acids.

  2005cites this paper
• Catechol releases iron(III) from ferritin by direct chelation without iron(II) production.

  2005cites this paper
• Autoxidation and MAO-mediated metabolism of dopamine as a potential cause of oxidative stress: role of ferrous and ferric ions.

  2004cites this paper
• Electrochemical investigation into the redox activity of Fe(II)/Fe(III) in the presence of nicotine and possible relations to neurodegenerative diseases.

  2004cites this paper
• [The interaction of ferritin and myoglobin as inductors of lipid peroxidation. The role of reactive oxygen and nitrogen species].

  2004cites this paper
• Electrochemistry on-line with mass spectrometry : instrumental methods for in vitro generation and detection of drug metabolites

  2004cites this paper
• Protective effect of resveratrol against 6-hydroxydopamine-induced impairment of renal p-aminohippurate transport

  2004cites this paper
• Structure-activity relationship of coordinated catecholamine in the [Ru(III)(NH3)4(catecholamine)]+ complex.

  2004cites this paper
• Effect of 6‐hydroxydopamine on gluconeogenesis in the rat renal cortex

  2003cites this paper
• Impairment of the renal p‐aminohippurate transport induced by 6‐hydroxydopamine

  2003cites this paper
• Antioxidant properties of newly synthesized N-propargylamine derivatives of nitroxyl: a comparison with deprenyl.

  2003cites this paper
• Influence of Carbohydrate Ingestion on Oxidative Stress and Plasma Antioxidant Potential Following a 3 h Run

  2003cites this paper
• Regulation of ferritin genes and protein.

  2002cites this paper